SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001323228-05-000001
Filing Date
2005-04-07
Accepted
2005-04-07 17:58:52
Documents
1
Period of Report
2005-03-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1568
  Complete submission text file 0001323228-05-000001.txt   3450
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Issuer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CELLEGY PHARMACEUTICALS, INC. 1000 MARINA BLVD., SUITE 300 BRISBANE CA 94005
Business Address (650) 616-2210
Caso Robert J (Reporting) CIK: 0001323228 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26372 | Film No.: 05740062